Proteomic and Transcriptomic studies in a number of cancer types have displayed an upregulation of GPC-3 expression, suggesting GPC-3 to be a useful marker for hepatocellular carcinoma (HCC). This evidence concerns the gene GPC3 and hepatocellular carcinoma.